arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

MaxCyte, Inc.

MXCT Health Care Biotechnology: Commercial Physical & Biological Resarch
$1.43
0.0% Today
as of Oct 22, 16:50 ET
Last 30 days +21.70% Sep 14 → Oct 22
$0.92 $1.07 $1.22 $1.36 $1.51 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$1.44
High
$1.50
Low
$1.43
Volume
$1M
Avg Vol
$1M
Mkt Cap
$112M
P/E (TTM)
—
Beta
—
52w High
$1.80
52w Low
$0.64
Div Yield
—
Shares Out
$106M

Recent Press Releases & News last 60 days · 3 items

Oct 14 · 12:05 PR GlobeNewswire
MaxCyte Reports Preliminary Third Quarter 2026 Revenue and Raises Full Year 2026 Revenue Guidance
Sep 23 · 12:05 PR GlobeNewswire
MaxCyte Appoints Sidharth Kapileshwar as Chief Corporate Development Officer
Sep 11 · 20:30 PR GlobeNewswire
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MXCT earnings at a glance

The options market is pricing a move of about ±68.8% after the report, a range of roughly $0.45 to $2.41 from today's $1.43. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±1.8% on average; after the most recent report on May 12, 2026 it moved +0.6%. That means options currently expect more movement than MXCT has typically delivered. MXCT beat the consensus EPS estimate in 1 of its last 4 reported quarters. Implied volatility is currently 5%. The share price of $1.43 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.64
$1.80
68% of range
Avg surprise (last 4)
+7.7%
Avg reaction (last 2)
+1.8%
100% positive
Latest IV / EM
521%
EM ±68.8% · $1 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.62$-0.35$-0.08$0.19$0.46 Actual $-0.11Actual $-0.10Actual $-0.11Actual $-0.09Actual $-0.11Actual $-0.10Est $-0.10Actual $-0.12Est $-0.10Actual $-0.12Est $-0.11Actual $-0.04Est $-0.10Actual $-0.08 MarJunSepJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-12M$-7M$-753,250$5M$11M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.08 — — — — financials
Tue May 12, 2026Mar/2026 $-0.04 $-0.10 +60.0% +60.0% +0.6% earnings
Wed Nov 12, 2025Sep/2025 $-0.12 $-0.11 -9.1% — — earnings
Wed Aug 6, 2025Jun/2025 $-0.12 $-0.10 -20.0% — — earnings
Wed May 7, 2025Mar/2025 $-0.10 $-0.10 0.0% — +3.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.11 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.09 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.11 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.10 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.11 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$7M$10M—$7M$9M$10M—$8M
Cost of revenue$2M$2M—$2M$2M$1M—$2M
Gross profit$6M$8M—$5M$7M$9M—$6M
Operating income$-10M$-6M—$-14M$-14M$-12M—$-14M
Net income$-9M$-5M—$-12M$-12M$-10M—$-12M
EPS (diluted)$-0.08$-0.04—$-0.12$-0.12$-0.10—$-0.11

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$15M$15M$20M$13M$15M$23M$28M$37M
Inventory$8M$8M$8M$8M$8M$8M$9M$10M
Total current assets$121M$123M$118M$125M$143M$156M$172M$173M
Total assets$185M$194M$203M$213M$220M$230M$239M$249M
Long-term debt————————
Total liabilities$26M$27M$31M$33M$29M$31M$33M$35M
Total equity$159M$168M$171M$180M$191M$199M$206M$213M

Implied volatility — last 90 days

170%1404%2639%3874%5109% Jun 23 — IV 437% · EM ±89.4%Jun 24 — IV 357% · EM ±71.4%Jun 26 — IV 316% · EM ±60.5%Jul 20 — IV 1773% · EM ±418.8%Jul 22 — IV 978% · EM ±223.7%Jul 23 — IV 1489% · EM ±334.8%Jul 24 — IV 2074% · EM ±458.3%Jul 27 — IV 1362% · EM ±284.3%Jul 28 — IV 2793% · EM ±571.4%Jul 29 — IV 2853% · EM ±571.4%Jul 31 — IV 2961% · EM ±566.7%Aug 03 — IV 1609% · EM ±285.0%Aug 04 — IV 2878% · EM ±495.5%Aug 05 — IV 2154% · EM ±359.8%Aug 07 — IV 3200% · EM ±500.0%Aug 10 — IV 1700% · EM ±235.5%Aug 11 — IV 1677% · EM ±221.5%Aug 12 — IV 1657% · EM ±207.6%Aug 13 — IV 3411% · EM ±402.9%Aug 14 — IV 2571% · EM ±284.1%Aug 17 — IV 2010% · EM ±167.9%Aug 19 — IV 3228% · EM ±190.6%Aug 20 — IV 4425% · EM ±184.8%Aug 24 — IV 879% · EM ±183.5%Aug 25 — IV 1593% · EM ±325.9%Aug 26 — IV 896% · EM ±179.4%Aug 28 — IV 1949% · EM ±373.0%Aug 31 — IV 1107% · EM ±196.2%Sep 02 — IV 1791% · EM ±299.2%Sep 09 — IV 2551% · EM ±319.7%Sep 10 — IV 2706% · EM ±319.6%Sep 11 — IV 1989% · EM ±219.8%Sep 14 — IV 2598% · EM ±217.0%Sep 15 — IV 3195% · EM ±231.1%Sep 17 — IV 5110% · EM ±213.4%Sep 21 — IV 353% · EM ±73.8%Sep 22 — IV 335% · EM ±68.5%Sep 23 — IV 650% · EM ±130.3%Sep 24 — IV 343% · EM ±67.2%Sep 25 — IV 357% · EM ±68.4%Sep 29 — IV 492% · EM ±84.7%Sep 30 — IV 420% · EM ±70.2%Oct 01 — IV 170% · EM ±27.5%Oct 02 — IV 329% · EM ±51.4%Oct 06 — IV 521% · EM ±68.8%

Sector peers

ONMD
OneMedNet Corp
$33M $4.91+3.4%
NOTV
Inotiv, Inc.
$10M $0.08
BIAF
bioAffinity Technologies, Inc.
$7M $3.17-13.4%
ISPC
iSpecimen Inc.
$6M $0.83-13.3%
NRC
NRC Health
$447M $21.38+3.3%
OABI
OmniAb, Inc.
$663M $4.78-3.6%

MXCT earnings FAQ

What is MXCT's expected move for earnings?

Options currently price a move of about ±68.8%, or $0.98 per share either way from $1.43.

How does MXCT stock usually react to earnings?

Across the last 2 reports the average next-day move was ±1.8%, up 2 times and down 0 times.

What is MXCT's implied volatility?

MXCT's at-the-money implied volatility is about 5% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in